Latest Articles
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting - Femtech Insider
Cyclana Bio Raises £5M to Reverse Endometriosis Through Extracellular Matrix Targeting Femtech Insider
Published: Oct. 20, 2025, 8:02 a.m.
Round up: Restoring immunity in menopausal women with HRT and more - FemTech World
Round up: Restoring immunity in menopausal women with HRT and more FemTech World
Published: Oct. 15, 2025, 1:20 p.m.
Caisse Française de Financement Local: EMTN 2025-7C GREEN - The Manila Times
Caisse Française de Financement Local: EMTN 2025-7C GREEN The Manila Times
Published: Oct. 14, 2025, 1:26 p.m.
How femtech is closing the gender gap in healthcare and research - FemTech World
How femtech is closing the gender gap in healthcare and research FemTech World
Published: Oct. 13, 2025, 8:06 a.m.
University of Arizona Researcher Receives $3 Million Grant for Endometriosis Detection Device - Femtech Insider
University of Arizona Researcher Receives $3 Million Grant for Endometriosis Detection Device Femtech Insider
Published: Oct. 9, 2025, 1:54 p.m.
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Oct. 8, 2025, 7:30 p.m.
Managers still unprepared to discuss menstrual health, study finds - FemTech World
Managers still unprepared to discuss menstrual health, study finds FemTech World
Published: Oct. 8, 2025, 11:02 a.m.
Genie Fertility Raises $1.22M to Develop Non-Invasive Uterine Diagnostics Using Menstrual Blood - Femtech Insider
Genie Fertility Raises $1.22M to Develop Non-Invasive Uterine Diagnostics Using Menstrual Blood Femtech Insider
Published: Oct. 7, 2025, 11:58 a.m.
Visana Health Raises $24M Series A to Scale Virtual-First Women’s Health Clinic - Femtech Insider
Visana Health Raises $24M Series A to Scale Virtual-First Women’s Health Clinic Femtech Insider
Published: Sept. 30, 2025, 11:05 a.m.
Dual Targeting of Orphan Nuclear Receptors NR4A1 and NR4A2 for Non-Hormonal Endometriosis Therapy.
Previous studies show that orphan nuclear receptor 4A1 (NR4A1) regulated endometriotic cell growth, survival, estrogen receptor β (ERβ), mTOR signaling and fibrosis. NR4A2 is also expressed in epithelial and stromal …
Published: Sept. 26, 2025, midnight
Link copied to clipboard!